Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
56,700
+500 (0.89%)
At close: Apr 29, 2026

KRX:317450 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
31,79232,89734,44918,25152,967
Upgrade
Short-Term Investments
477,901227,399153,080124,43467,786
Upgrade
Cash & Short-Term Investments
509,692260,296187,529142,686120,753
Upgrade
Cash Growth
95.81%38.80%31.43%18.16%70.83%
Upgrade
Accounts Receivable
63,65160,77158,14756,78356,688
Upgrade
Other Receivables
5,0553,4923,7112,7102,138
Upgrade
Receivables
68,87064,43362,02059,64659,033
Upgrade
Inventory
64,10860,34356,27747,88046,732
Upgrade
Prepaid Expenses
538.02510.71434.13533.52243.22
Upgrade
Other Current Assets
100.97225.491,32972.68176.49
Upgrade
Total Current Assets
643,309385,809307,589250,818226,938
Upgrade
Property, Plant & Equipment
118,51399,25999,309103,706110,187
Upgrade
Long-Term Investments
10,21910,78328,60824,2426,804
Upgrade
Other Intangible Assets
5,520713.02710.9711.01711.69
Upgrade
Long-Term Accounts Receivable
1,9242,2312,0392,3002,545
Upgrade
Long-Term Deferred Tax Assets
----4.51
Upgrade
Other Long-Term Assets
61,94382,71783,11989,52882,344
Upgrade
Total Assets
841,675581,692521,590471,556429,760
Upgrade
Accounts Payable
6,3018,2982,3972,1292,245
Upgrade
Accrued Expenses
1,2071,3271,4251,2962,290
Upgrade
Current Portion of Leases
1,1751,5281,7271,7391,329
Upgrade
Current Income Taxes Payable
11,45812,38912,94911,47213,494
Upgrade
Current Unearned Revenue
17.32----
Upgrade
Other Current Liabilities
26,02621,05920,68618,45820,374
Upgrade
Total Current Liabilities
46,18444,60239,18435,09339,732
Upgrade
Long-Term Leases
211.161,1722,1603,2064,281
Upgrade
Long-Term Unearned Revenue
7.2970.23115.85161.47-
Upgrade
Pension & Post-Retirement Benefits
----668.61
Upgrade
Long-Term Deferred Tax Liabilities
1.661,4395,3276,6846,605
Upgrade
Other Long-Term Liabilities
892.392,5892,4892,4322,382
Upgrade
Total Liabilities
47,29749,87149,27647,57753,668
Upgrade
Common Stock
7,3005,6005,6005,6005,600
Upgrade
Additional Paid-In Capital
192,082----
Upgrade
Retained Earnings
602,371533,269471,701421,245373,297
Upgrade
Comprehensive Income & Other
-7,375-7,049-4,988-2,866-2,805
Upgrade
Shareholders' Equity
794,378531,821472,314423,979376,092
Upgrade
Total Liabilities & Equity
841,675581,692521,590471,556429,760
Upgrade
Total Debt
1,3862,7003,8874,9455,609
Upgrade
Net Cash (Debt)
508,306257,596183,642137,740115,143
Upgrade
Net Cash Growth
97.33%40.27%33.32%19.63%80.64%
Upgrade
Net Cash Per Share
41932.7022998.4816396.6212298.2510280.65
Upgrade
Filing Date Shares Outstanding
14.6311.211.211.211.2
Upgrade
Total Common Shares Outstanding
14.6311.211.211.211.2
Upgrade
Working Capital
597,125341,207268,406215,724187,206
Upgrade
Book Value Per Share
54305.3047483.9842170.8937855.2833579.64
Upgrade
Tangible Book Value
788,858531,108471,603423,268375,380
Upgrade
Tangible Book Value Per Share
53927.9547420.3142107.4137791.8033516.10
Upgrade
Land
39,46639,46739,08937,09836,955
Upgrade
Buildings
59,27359,17959,29159,02058,923
Upgrade
Machinery
98,43095,86590,30487,40385,970
Upgrade
Construction In Progress
30,9165,2361,374258.5286.44
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.